Investing Insights Report

Software stocks have always been expensive, up until a few months ago.

Deckers Outdoor, Matador Resources and FactSet Research are 3 picks for solid sales growth as U.S. markets climb toward record highs.

Amplify Energy & Natural Resources Covered Call ETF (NYSE:NDIV) targets income-hungry investors who want exposure to oil, gas, and chemicals without sacrificing yield.

CVE, TTE and CPCAY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 21st, 2026.

Year to date, Micron Technology and Comfort Systems shares have outperformed Nvidia and Palantir shares by a considerable margin. Micron is a key manufacturer of DRAM, HBM, and NAND flash memory chips that support artificial intelligence workloads in data centers.

The ancillary cannabis sector continues to gain attention in April 2026. These companies support the industry without touching the plant. As a result, they avoid many regulatory risks associated with federal law.

Now that fears about the supply of oil are easing, S&P 500 investors are thinking about growth again. And some companies can deliver.

Major defense stocks aren’t rising as the Iran war proceeds — they’re falling instead. Multiple defense stocks are now within striking distance of an attractive valuation.

Shares of psychedelics-related stocks climbed in early trade on Monday after US president Donald Trump signed an executive order aimed at accelerating research into psychedelic-assisted therapies and expanding patient access for certain serious mental health conditions, including post-traumatic stress disorder (PTSD) and treatment-resistant depression. The executive order, signed by Trump on Saturday, directs the US Food and Drug Administration (FDA) Commissioner to prioritize review pathways for psychedelic drugs that have received Breakthrough Therapy designation for serious mental illnesses and meet criteria under a national voucher program designed to speed regulatory review.

The only drug named in Trump’s executive order is ibogaine, a psychedelic commonly used to treat depression, anxiety and PTSD among veterans. The drug, a Schedule I substance banned in the U.S., has been backed by Republicans in Texas in recent years who argue in favor of ibogaine’s success with veterans.